iBio Inc. [IBIO] stock is down -0.56 while the S&P 500 has fallen -0.17% on Thursday, 11/19/20. While at the time of this article, IBIO ATR is sitting at 0.14, with the beta value at -5.74. This stock’s volatility for the past week remained at 9.12%, while it was 6.93% for the past 30-day period. IBIO has fallen -$0.01 from the previous closing price of $1.62 on volume of 3.54 million shares.

On 16, November 2020, iBio Reports Fiscal First Quarter 2021 Financial Results and Provides Corporate Update. According to news published on Yahoo Finance, iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced its financial results for the fiscal quarter ended September 30, 2020.

Analyst Birdseye View:

Before that, on June 26, 2020, Alliance Global Partners Recapitulated a Buy rating and elevated its amount target to $2.55.

In the past 52 weeks of trading, this stock has oscillated between a low of $0.10 and a peak of $7.45. Right now, the middling Wall Street analyst 12-month amount mark is $2.00. At the most recent market close, shares of iBio Inc. [AMEX:IBIO] were valued at $1.61. According to the average price forecast, investors can expect a potential return of -55.0%.


iBio Inc. [AMEX:IBIO] most recently reported quarterly sales of 1.12 billion, which represented growth of 37.50%. This publicly-traded organization’s revenue is $409,500 per employee, while its income is -$4,109,750 per employee. Continuing to look at profitability, this corporation’s Return on Assets, Equity, Whole Principal & invested Principal is sitting at -26.35, -55.65, -23.97 and -28.32 respectively.

If looking now at the Principal structure of this organization, it shows its whole liability to the whole Principal at 36.76 and the whole liability to whole assets at 34.94. It shows enduring liability to the whole principal at 36.13 and enduring liability to assets at 0.34 while looking for an extended time period.

Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 1.5700 points at 1st support level, the second support level is making up to 1.5200. But as of 1st resistance point, this stock is sitting at 1.6700 and at 1.7200 for 2nd resistance point.

iBio Inc. [IBIO] reported its earnings at -$0.05 per share in the fiscal quarter closing of 9/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.08/share signifying the difference of 0.03 and 37.50% surprise value.

Important Ratio’s To Watch

Meanwhile, turning our focus to liquidity, the Current Ratio for iBio Inc. [AMEX:IBIO] is 11.80. Likewise, the Quick ratio is also the same, showing Cash ratio at 10.53. Now if looking for a valuation of this stock’s amount to sales ratio it’s 85.11 and it’s amount to book ratio is 5.49.

Insider Stories

The most recent insider trade was by Eastern Capital LTD, 10% Owner, and it was the sale of 15.86 million shares on Aug 11. Eastern Capital LTD, the 10% Owner, completed a sale of 7.26 million shares on Aug 10. On Aug 07, Eastern Capital LTD, 10% Owner, completed a sale of 1.36 million shares.